AZN AstraZeneca PLC Loading...

From BXP earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
14:00
Jul 29 ◎
Owen Thomas Chairman and CEO, BXP, Inc. BXP Q2 FY26 call
AstraZeneca is a fully committed tenant for the delivered life sciences building in Cambridge.
AZN
HIGH
14:00
Apr 29 ◎
Mike LaBelle CFO, BXP, Inc. BXP Q1 FY26 call
AstraZeneca has started paying rent on BXP's development ahead of schedule, a positive sign for the delivery and cash flow of the project.
AZN
HIGH
15:00
Jan 28 ◎
Mike LaBelle CFO, BXP, Inc. BXP Q4 FY25 call
AstraZeneca is the anchor tenant for BXP's largest 2026 development delivery, providing stable, contracted NOI growth.
AZN
HIGH

About AZN Analyst Coverage

Buzzberg tracks AZN (AstraZeneca PLC) across 1 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Latest voices: Owen Thomas, Mike LaBelle.